AbCellera Biologics, Inc. (ABCL)
12.61
-0.02
(-0.20%)
USD |
NASDAQ |
Oct 13, 16:00
12.49
-0.12
(-0.95%)
Pre-Market: 08:56
AbCellera Biologics Research and Development Expense (TTM) : 197.77M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 197.77M |
| March 31, 2026 | 191.00M |
| December 31, 2025 | 186.83M |
| September 30, 2025 | 182.81M |
| June 30, 2025 | 168.75M |
| March 31, 2025 | 170.47M |
| December 31, 2024 | 167.26M |
| September 30, 2024 | 169.80M |
| June 30, 2024 | 166.75M |
| March 31, 2024 | 162.30M |
| December 31, 2023 | 175.66M |
| Date | Value |
|---|---|
| September 30, 2023 | 155.28M |
| June 30, 2023 | 143.95M |
| March 31, 2023 | 134.16M |
| December 31, 2022 | 107.88M |
| September 30, 2022 | 96.84M |
| June 30, 2022 | 87.71M |
| March 31, 2022 | 76.07M |
| December 31, 2021 | 62.06M |
| September 30, 2021 | 53.48M |
| June 30, 2021 | 43.53M |
| March 31, 2021 | 41.74M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| MindWalk Holdings Corp. | 3.824M |
| Agilent Technologies, Inc. | 480.00M |
| Bio-Rad Laboratories, Inc. | 260.70M |
| Bruker Corp. | 393.50M |
| Azenta, Inc. | 35.73M |